Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

A Ana C. Garrido-Castro N Noah Graham K Katelyn X. Li L Lynn Bi J Jett Crowdis K Kevin Bi J Jihye Park (Department of Chemistry) R Ricardo Pastorello Y Yvonne Li H Hersh Gupta T Thomas Kuntz R Russell Petry L Lincoln W. Pasquina A Ashka Patel P Paulina Lange M Molly DiLullo V Victoria Attaya A Anna Mae Frey M Merrida A. Childress R Robert Wesolowski N Natalie Sinclair S Sarah Sinclair S Steve Lo N Nadine Tung M Meredith Faggen P Peter A. Kaufman C Caroline C. Block J Jeanna Walsh M Madhavi Toke W Wendy Chen K Kai W. Wucherpfennig (Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.) Y Ye Tian A Amy J. Williams (Department of Geological Sciences, University of Florida) S Satabhisa Mukhopadhyay T Tathagata Dasgupta S Stuart Schnitt A Andrew D. Cherniack R Romualdo Barroso J Jennifer Ligibel N Nancy U. Lin E Elizabeth A. Mittendorf N Nabihah Tayob E Eliezer Van Allen S Sara M. Tolaney (Department of Medical Oncology, Dana-Farber Cancer Institute)